Medical Quality Control Indicators for Amyotrophic Lateral Sclerosis
In 2022,the National Center for Healthcare Quality Management in Neurological Diseases set up the Motor Neuron Disease(MND)Working Group and started the construction of medical quality control system for amyotrophic lateral sclerosis(ALS)/MND.Through systematic investigation of evidence-based medicine evidence and domestic and foreign guidelines,the working group formulated the ALS medical quality control indicator system by using Delphi method,and systematically improved the quality control process of ALS in patient diagnosis and treatment from the aspects of unifying diagnostic criteria,establishing the concept of comprehensive management and standardizing treatment plans.The system includes 15 indicators,which will provide the first set of quantitative tools for monitoring the implementation of medical quality improvement of ALS in China.Through the continuous monitoring of this indicators system,the systematic comparison of treatment quality control could be carried out.With the help of this quality control system,medical staff can improve their understanding of ALS,and clinical medical behaviors can be standardized,thus establishing medical standards and continuous quality improvement system for MND in China.
Amyotrophic lateral sclerosisMedical qualityQuality control indicator
万方数据
维普
